Sathishkumar Chidambaram | Nanochemistry | Best Researcher Award

Dr. Sathishkumar Chidambaram | Nanochemistry | Best Researcher Award

Assistant Professor at Annai Maathammal Sheela Engineering College | India

Dr. Sathishkumar Chidambaram is a dedicated researcher in the field of chemistry with expertise spanning organic synthesis, nano catalysis, computational chemistry, and drug design. His doctoral work focused on the design and synthesis of novel benzopyran and pyrimidine derivatives, with applications in mosquito larvicidal activity and ecological safety. He has contributed significantly to green chemistry approaches, utilizing eco-friendly catalysts to develop biologically active compounds. His research interests extend into density functional theory, molecular docking, and pharmacokinetics, enabling him to bridge theoretical and practical aspects of drug discovery. With multiple publications in reputed international journals, his work has addressed critical challenges such as antimicrobial resistance and viral infections, including investigations against SARS-CoV-2. Proficient in advanced software and instrumental techniques, Dr. Sathishkumar demonstrates strong interdisciplinary skills and collaboration. His research highlights innovation, societal relevance, and a commitment to sustainable solutions in chemical and biomedical sciences, positioning him as a promising contributor to global research.

Professional Profile 

Google Scholar | Scopus Profile

Education

Dr. Sathishkumar Chidambaram has pursued an extensive academic journey in the field of chemistry, demonstrating consistent excellence throughout his studies. He earned his Bachelor of Science degree in Chemistry, where he developed a strong foundation in fundamental chemical sciences. Building on this, he completed his Master of Science degree in Chemistry with distinction, engaging in research on adsorption studies of dye effluents using natural adsorbents, which reflected his early interest in applied and environmental chemistry. His passion for advanced research led him to undertake a Doctor of Philosophy in Chemistry, focusing on organic synthesis, nano catalysis, computational chemistry, and drug design. His doctoral thesis emphasized the design and synthesis of novel benzopyran and pyrimidine derivatives, with applications in mosquito larvicidal activity and toxicity studies. This progression highlights his steady growth as a scholar, transitioning from basic studies to specialized, application-driven research with strong interdisciplinary and societal relevance.

Experience

Dr. Sathishkumar Chidambaram has gained valuable research experience through years of dedicated academic and scientific work. His early research experience began during his master’s degree, where he explored adsorption methods for dye effluent removal using groundnut shell derivatives, which introduced him to applied chemistry and environmental sustainability. During his doctoral studies, he advanced his expertise by engaging in cutting-edge research on the synthesis of bioactive compounds, nano catalysis, and computational approaches, particularly focusing on mosquito control and drug design. His extensive work includes handling sophisticated instruments such as ATR-FTIR and GC-MS, as well as utilizing advanced computational tools like Autodock, Pymol, Discovery Studio, and Gaussian. His collaborative experience is reflected in his numerous international publications across reputed journals, where he has contributed to studies on antiviral, antimicrobial, and eco-friendly chemical applications. This blend of experimental and computational expertise has shaped him into a versatile researcher with both depth and breadth in the chemical sciences.

Research Focus

Dr. Sathishkumar Chidambaram’s research focus lies at the intersection of organic synthesis, green chemistry, computational modeling, and biomedical applications. He has specialized in developing novel benzopyran, pyrimidine, coumarin, and pyrazole derivatives with potential larvicidal, antimicrobial, antiviral, and anticancer properties. His work emphasizes environmentally sustainable approaches, particularly through the use of green catalysts such as Cu(II)-tyrosinase enzyme systems, reflecting a strong commitment to eco-friendly methodologies. In addition to experimental synthesis, he integrates density functional theory, molecular docking, and pharmacokinetic analyses to predict and validate the biological activities of compounds. His contributions to drug discovery include in silico investigations targeting viral proteins, notably SARS-CoV-2, and antimicrobial studies addressing resistant pathogens. By combining computational and experimental techniques, his research not only advances fundamental chemical knowledge but also contributes practical solutions to global health and environmental challenges. His multidisciplinary focus demonstrates innovation, sustainability, and real-world applicability in modern chemical research.

Award and Honor

Dr. Sathishkumar Chidambaram’s contributions to research have been recognized through multiple academic honors and achievements. During his academic journey, he earned distinction in his master’s program, reflecting his consistent academic excellence and dedication to chemistry. His doctoral work, commended for its originality and interdisciplinary approach, highlights his growing reputation as a skilled researcher in organic synthesis, nanocatalysis, and computational drug design. His impactful publications in internationally reputed journals serve as a testament to the recognition of his work by the global scientific community, as his research addresses pressing issues such as eco-friendly synthesis, mosquito-borne disease control, and drug discovery against emerging pathogens. While much of his recognition comes in the form of scholarly publications and citations, his evolving academic career positions him as a strong candidate for research awards and honors that celebrate innovation, societal relevance, and scientific contribution. His work continues to gain visibility, building toward broader recognition in the field.

Publication Top Notes

  • Title: In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
    Authors: SK Chidambaram, D Ali, S Alarifi, S Radhakrishnan, I Akbar
    Year: 2020
    Citations: 61

  • Title: Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies
    Authors: S Chidambaram, MA El-Sheikh, AH Alfarhan, S Radhakrishnan, I Akbar
    Year: 2021
    Citations: 41

  • Title: Synthesis, cytotoxic analysis, and molecular docking studies of tetrazole derivatives via N-Mannich base condensation as potential antimicrobials
    Authors: A Atef Hatamleh, D Al Farraj, S Salah Al-Saif, SK Chidambaram, …
    Year: 2020
    Citations: 25

  • Title: Synthesis of novel benzopyran-connected pyrimidine and pyrazole derivatives via a green method using Cu(II)-tyrosinase enzyme catalyst as potential larvicidal, antifeedant activities
    Authors: C SathishKumar, AAF Mostafa, AA Al-Askar, SRM Sayed, …
    Year: 2019
    Citations: 17

  • Title: Antimicrobial activity of novel 5-benzylidene-3-(3-phenylallylideneamino) imidazolidine-2,4-dione derivatives causing clinical pathogens: Synthesis and molecular docking studies
    Authors: D Ali, S Alarifi, SK Chidambaram, SK Radhakrishnan, I Akbar
    Year: 2020
    Citations: 15

  • Title: Tyrosinase-mediated synthesis of larvicidal active 1,5-diphenyl pent-4-en-1-one derivatives against Culex quinquefasciatus and investigation of their ichthyotoxicity
    Authors: SK Chidambaram, D Ali, S Alarifi, R Gurusamy, SK Radhakrishnan, …
    Year: 2021
    Citations: 12

  • Title: Larvicidal activity of novel anthraquinone analogues and their molecular docking studies
    Authors: K Selvaraj, D Ali, S Alarifi, SK Chidambaram, S Radhakrishnan, I Akbar
    Year: 2021
    Citations: 12

  • Title: CuII‐Tyrosinase Enzyme Catalyst‐Mediated Synthesis of 2‐Thioxopyrimidine Derivatives with Potential Mosquito Larvicidal Activity: Spectroscopic and Computational Investigation
    Authors: C SathishKumar, S Keerthana, A Ahamed, IA Arif, R SurendraKumar, …
    Year: 2020
    Citations: 10

  • Title: Green catalyst Cu(II)-enzyme-mediated eco-friendly synthesis of 2-pyrimidinamines as potential larvicides against Culex quinquefasciatus mosquito and toxicity investigation against non-target aquatic species
    Authors: SK Chidambaram, AAF Mostafa, AA Al-Askar, SRM Sayed, …
    Year: 2021
    Citations: 9

  • Title: Antioxidant Activity of Telmisartan–Cu(II) Nanoparticles Connected 2‐Pyrimidinamine and Their Evaluation of Cytotoxicity Activities
    Authors: R Surendrakumar, A Idhayadhulla, S Alarifi, NA Ahamed, SK Chidambaram, …
    Year: 2020
    Citations: 7

  • Title: Bis-(N-aminoethylethanolamine)-Copper(II) nanocatalysis (AEEA-Cu(II)-NPs) mediated synthesis of a series of 2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide derivatives
    Authors: C SathishKumar, R Surendrakumar, G Raman, D Ali, S Alarifi, …
    Year: 2022
    Citations: 4

Conclusion

Dr. Sathishkumar Chidambaram has established himself as a promising researcher with impactful contributions in organic synthesis, nano catalysis, computational chemistry, and drug design. His publications reflect both innovation and societal relevance, addressing global challenges such as mosquito-borne diseases, antimicrobial resistance, and emerging viral infections like SARS-CoV-2. By combining experimental synthesis with advanced computational approaches, he has demonstrated strong interdisciplinary expertise. His work, recognized through citations and international collaborations, highlights his ability to translate fundamental research into practical applications. With a growing research profile and commitment to sustainable and eco-friendly methodologies, Dr. Sathishkumar stands out as a deserving candidate for recognition as a Best Researcher, showcasing potential for continued excellence and leadership in the field of chemical and biomedical sciences.